secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0000014272-23-000150
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BMY Q2 revenue $11.2B, GAAP EPS $0.99, non-GAAP $1.75; cuts FY guidance on Revlimid decline
--------------------------------------------------------------------------------

- Q2 revenue $11.2B, down 6% YoY (5% ex-FX); GAAP EPS $0.99 (up 50% YoY), non-GAAP EPS $1.75 (down 9% YoY).
- Revlimid decline faster than expected; FY guidance revised: revenue low single-digit decline, GAAP EPS $3.72-$4.02, non-GAAP EPS $7.35-$7.65.
- In-line and new product portfolio grew 4% YoY; pipeline and regulatory milestones advanced.
- Announced $4B accelerated share repurchase agreement expected to execute in Q3 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000001427223000150/0000014272-23-000150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000001427223000150/bmy-20230727.htm
  HTML page:      https://secwatch.observer/filing/0000014272-23-000150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer